Implications of Expanded Biosimilar Use in the United States' Dermatology, Gastroenterology, and Rheumatology Markets Highlighted in New Spherix Study

/PRNewswire/ -- Biosimilars are biopharmaceutical products that are nearly identical copies of drugs that have previously been licensed (reference products),...

Related Keywords

United States ,Amgen Enbrel ,Samsung Biopi Hadlima ,Boehringer Ingelheim Cyltezo ,Janssen Stelara ,Takeda Entyvio ,Abbvie Humira ,Prnewswire Biosimilars ,Merck Hadlima ,Paul Zimmerman ,Amgen Avsola ,Amgen Amjevita ,Mylan Hulio ,Coheru Yusimry ,Genentech Actemra ,Sandoz Hyrimoz ,Merck Renflexis ,Global Insights ,Special Topix ,Biosimilars Today ,Realtime Dynamix ,Boehringer Ingelheim ,Vice President ,